Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

7.07USD
6 Jul 2015
Change (% chg)

$0.10 (+1.43%)
Prev Close
$6.97
Open
$6.91
Day's High
$7.40
Day's Low
$6.75
Volume
491,329
Avg. Vol
293,750
52-wk High
$9.27
52-wk Low
$4.03

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc.is engaged in developing medicines for oncology. The Company completed Phase II clinical trials of two product candidates for prostate cancer, and resumed a pivotal Phase II trial of an ultra-orphan radiotherapy candidate for pheochromocytoma. Its principal clinical-stage product candidates in... (more)

Overall

Beta: 1.78
Market Cap(Mil.): $485.43
Shares Outstanding(Mil.): 69.64
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 108.79 35.83 39.81
EPS (TTM): 0.06 -- --
ROI: 2.46 17.03 16.23
ROE: 3.11 17.93 17.36
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks